Business Standard

SPARC's Sept quarter loss widens to Rs 63 cr from Rs 2.58 cr last year

Shares of SPARC were trading at Rs 146.7 apiece, up 2.34% on the BSE

SPARC

Press Trust of India New Delhi

Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the ongoing fiscal.

The company had reported a loss of Rs 2.58 crore for July-September, 2018-19.

Total income declined to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period, SPARC said in a regulatory filing.

Shares of SPARC were trading at Rs 146.7 apiece, up 2.34 per cent on the BSE.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 04 2019 | 3:00 PM IST

Explore News